U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday.
The value of shares belonging to the esteemed Koninklijke Philips N.V. (PHG) plunged in pre-market trading today after the company presented their fourth-quarter financial report. Distressingly, the company came to terms with the US Department of Justice, representing the FDA, on the specifics of a consent decree that focuses on Philips Respironics in the US.
Philips shares withered by a disheartening 5.6% to $21.48 in pre-market trading.
Here’s a breakdown of some significant stocks floundering in today’s pre-market trading session.
- Nukkleus Inc. (NUKK) shares fell 9.7% to $0.9486 in pre-market trading. Nukkleus made the announcement of C. Derek Campbell joining its Board of Directors.
- Atlanta Braves Holdings, Inc. (BATRK) experienced a 6.5% decline, now resting at $37.70 in pre-market trading.
- BrightSpring Health Services, Inc. (BTSG) shares slipped by 3.6% to $10.61 in pre-market trading after a fall of around 15% on Friday.
- GigaCloud Technology Inc. (GCT) dropped by 4.4% to $24.50 in pre-market trading after rising 10% on Friday.
- Revance Therapeutics, Inc. (RVNC) experienced a 4.4% decline, now resting at $5.70 in pre-market trading. The company recently issued preliminary fourth-quarter and FY23 financial results and guidance.
- MorphoSys AG (MOR) fell by 4.2% to $11.04 in pre-market trading after jumping over 16% on Friday. Morgan Stanley recently downgraded the stock from Overweight to Equal-Weight.
- Ryanair Holdings plc (RYAAY) observed a 3.5% drop to $125.50 in pre-market trading after the company reported third-quarter financial results and trimmed its profit outlook for the year.
Now Read This: Investor Sentiment Decreases Slightly Following PCE Inflation Data; S&P 500 Snaps Six-Session Win Streak
Don’t forget to check out our premarket coverage here
